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Abstract: Melittin is an anti-microbial peptide (AMP) and one of the most studied
membrane-disrupting peptides. There is, however, a lack of accurate measurements of
the concentration-dependent kinetics and affinity of binding of melittin to phospholipid
membranes. In this study, we used surface plasmon resonance spectroscopy
to determine the concentration-dependent effect on the binding of melittin to
1-palmitoyl-2-oleoyl-glycero-3-phosphocholine (POPC) bilayers in vesicles. Three concentration
ranges were considered, and when combined, covered two orders of magnitudes (0.04 µM to 8
µM), corresponding to concentrations relevant to the membrane-disrupting and anti-microbial
activities of melittin. Binding kinetics data were analysed using a 1:1 Langmuir-binding model
and a two-state reaction model. Using in-depth quantitative analysis, we characterised the effect
of peptide concentration, the addition of NaCl at physiological ionic strength and the choice of
kinetic binding model on the reliability of the calculated kinetics and affinity of binding parameters.
The apparent binding affinity of melittin for POPC bilayers was observed to decrease with increasing
peptide/lipid (P/L) ratio, primarily due to the marked decrease in the association rate. At all
concentration ranges, the two-state reaction model provided a better fit to the data and, thus, a more
reliable estimate of binding affinity. Addition of NaCl significantly reduced the signal response
during the association phase; however, no substantial effect on the binding affinity of melittin to
the POPC bilayers was observed. These findings based on POPC bilayers could have important
implications for our understanding of the mechanism of action of melittin on more complex model
cell membranes of higher physiological relevance.
Keywords: surface plasmon resonance; melittin; liposomes; peptide–lipid interactions; anti-microbial
peptides; pore-forming peptides
1. Introduction
Anti-microbial peptides (AMPs) are found throughout the animal and plant kingdom, where they
form an important part of the innate immune system [1]. Due to the fact of their potent activity
against Gram-positive and Gram-negative bacteria as well as other pathogens, AMPs have been
actively pursued as lead molecules for the development of new antimicrobial agents [2–5]. In addition,
AMPs have been investigated for their anti-cancer activity to address the issue of chemotherapy
resistance [6–8], and there is emerging evidence for their use as adjuvant cancer therapeutics [9,10].
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The cytotoxic effect of many AMPs primarily stems from their ability to lyse the phospholipid
bilayer of the plasma or mitochondrial cell membranes [11–13]. While AMPs show a wide range
of secondary structures and different mechanisms of action, they share certain physico-chemical
characteristics. Like other membrane-disruptive peptides, AMPs are positively charged (cationic) and
have a relatively large number of hydrophobic residues that are often clustered to give the peptide
an overall amphipathic character [5,11–15]. Their cationic nature enables electrostatic interactions
with the negatively charged (anionic) lipid head groups found in bacterial membranes, while the
amphipathic nature facilitates insertion into the hydrophobic core of the membrane. However,
there is still an incomplete understanding of the molecular mechanisms by which AMPs bind to
and, subsequently, disrupt cell membranes, as well as the physico-chemical factors affecting the
interaction [12]. Characterising the membrane-binding properties of AMPs is particularly important for
the development of therapeutic peptides (e.g., antibiotics or anti-cancer agents) with higher specificity
for microbes or cancer cells.
One of the most studied AMPs is melittin [16], the major component of honey bee venom [17].
Melittin is a 26 amino acid long cationic peptide and its cytolytic effects on lipid vesicles as well as on
bacterial and mammalian cells has been demonstrated in a large number of studies [18–27]. Early work
using nuclear magnetic resonance (NMR) and circular dichroism (CD) spectroscopy on the structure of
melittin in water and lipid environments showed that the peptide is mostly unstructured in solution
but undergoes a transition to α-helix upon binding to a lipid–water or hydrophobic interface [28–36].
Melittin is also known to dimerise and form higher-order oligomers under certain conditions such as
high peptide concentrations and high ionic strength [29,37–39].
The membrane-disrupting mechanism of melittin has been studied extensively using a wide range
of experimental and molecular simulation approaches [40]. Findings from these studies suggest that
membrane-bound melittin can be present in two orientations: parallel, where it lies on the membrane
surface interacting mostly with the lipid head groups, and perpendicular, where it is inserted into the
hydrophobic core of the membrane, oriented perpendicularly to the membrane surface. A two-step
model is often used to describe the mechanism of formation of membrane pores by melittin [26,41,42],
wherein the peptide, at low concentration, binds to the bilayer surface in a parallel conformation
and then shifts to a perpendicular orientation at higher concentration, leading to membrane pore
formation. The existence of two membrane-bound orientations has been demonstrated by molecular
simulation studies [43–48] and the retention of amphiphilic peptides in a surface-absorbed state has
been explained by elasticity theory [49].
A recent study has suggested a variation to this two-step model, in which the transition from parallel
to perpendicular does not occur but, rather, parallel surface binding and direct insertion are competing
processes [26]. Numerous studies of melittin make it clear that surface binding, membrane disruption
and pore formation constitute an inter-dependent and complex process. In addition, each one of these
processes is affected by environmental factors such as membrane lipid composition [23,27,39,50–53],
peptide concentration and peptide–lipid ratio [21,54], pH and ionic strength [51,53], and local membrane
curvature [55].
Like other AMPs, melittin exhibits preferred binding to negatively charged (anionic) lipids [53,56]
due to the strong electrostatic attraction between the C-terminal region of melittin and negatively
charged lipid headgroups [53]. It has been suggested that the basis for the strong attraction between
melittin and anionic lipids is an “electrostatic arrest” (adsorption) of melittin in its parallel (inactive)
orientation on the lipid surface [53]. Indeed, this postulate is used to explain the tolerance of
anionic liposomes to membrane disruption by melittin [32,57,58]. This suggests that, compared to
neutral (or zwitterionic membranes), the presence of anionic lipids promotes increased surface
adsorption but, by favouring the (inactive) parallel conformation of melittin, it also hinders pore
formation and, thus, reduces leakage. Likewise, melittin interacts with the headgroups of zwitterionic
lipids (e.g., phosphatidylcholine), but the interaction is much weaker than for anionic lipids (e.g.,
phosphatidylglycerol or phosphatidylinositol) [53,55,59,60].
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Among the most commonly used methods to study membrane binding of AMPs, including
melittin, are isothermal titration calorimetry (ITC) [61] and surface plasmon resonance (SPR) [62–65].
Other methods used for the study of melittin to lipid membranes include ultrafiltration assays [55,59]
and fluorescence measurements [53]. Isothermal titration calorimetry has been used to determine the
enthalpy (∆H), entropy (∆S) and free energy of binding (∆G) as well as the associated equilibrium
dissociation constant (KD) of the interaction between melittin and model cell membranes with various
lipid compositions [66,67]. Surface plasmon resonance has provided real-time measurements of the
association (ka) and dissociation rates (kd) of binding as well as estimates of ∆G for melittin–lipid
interactions [62,63,65,68]. In one of the earliest SPR studies, Aguilar and co-workers [64] reported on
the binding of melittin to dimyristoylphosphocholine (DMPC) and dimyristoylphosphatidylglycerol
(DMPG) using peptide concentrations between 10 and 140µM. While this concentration range is not high
enough to induce the formation of the tetrameric aggregate of melittin in solution [28,29,69–71], it may
likely cause the accumulation of the peptide on the membrane surface thus affecting both the subsequent
binding of melittin and the barrier properties of the lipid bilayer [72]. This is important because,
based on the classical carpet model [73], it has been postulated that, at high concentration, cationic
amphiphilic peptides (including melittin) can accumulate at the lipid surface creating an asymmetry of
mass, charge and surface pressure. Subsequently, this asymmetry is dissipated by the re-organization
of the lipid bilayer, leading to a transient increase in the permeability of the peptides across the lipid
bilayer until an equilibrium is established between both sides of the bilayer. A similar occurrence
of transient permeability and the subsequent appearance of resistance in the lipid bilayer following
the action of melittin has been shown in phosphatidylcholine (PC) vesicles at a peptide/lipid ratio of
1/200 [40]. Consequently, experiments conducted at high peptide concentrations could be problematic
when studying the interaction of peptides with lipid bilayers. In addition, the concentrations of melittin
required to induce leakage [17,18,24,25,55,57] are in the sub-µM to low-µM range, and using much
higher peptide concentrations might affect the relevance of the observed binding to the mechanism
of membrane disruption. In a more recent SPR study, Aguilar and co-workers [62] re-investigated
the interaction of melittin with DMPC at lower concentrations (0.125–12 µM). This study reported
a concentration-dependent change in binding (resonance units or RU levels); however, it did not
quantify the changes in binding affinity due to the reported poor fits for the 1:1 and two-state reaction
binding models.
In this study, we carried out SPR experiments of the binding of melittin to
1-palmitoyl-2-oleoylphosphatidylcholine (POPC) membranes using three sets of concentration ranges
that covered two orders of magnitude (0.04–8.0 µM), and also investigated the effect of ionic strength
on this interaction. To our knowledge, this is the first study reporting extensive quantitative analysis
of the concentration-dependent kinetics and binding affinity of melittin and how this might relate to
the various stages of its mechanism of membrane binding and insertion.
2. Results
The POPC SUVs were deposited on the L1 sensor chip at a flow rate of 5 µL/min for 60 min,
attaining an immobilization level up to a maximum of ~8400 RU. Following immobilization, multi-cycle
or single-cycle kinetics experiments were conducted and the resulting sensorgram data were fitted
to either the 1:1 Langmuir model or a two-state reaction model to estimate ka, kd and KD of the
melittin–POPC interaction. As noted in Section 2, single-cycle kinetics experiments were used for the
low-range and medium-range concentrations, while multi-cycle kinetics experiments were used for
the high-range concentrations.
2.1. Effect of Analyte Concentration on Kinetics Analysis
One of the aims of this study was to investigate the effect of melittin (analyte) concentration on
the apparent affinity of its interaction with POPC, the quality of fit to the data using different kinetic
binding models and the subsequent reliability of the estimated binding constants. Multi-cycle kinetics
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(MCK) or single-cycle kinetics (SCK) experiments were carried out with three different ranges of analyte
concentrations, referred to as high-range, mid-range and low-range. The analyte concentrations were:
0.5, 1, 2, 4 and 8 µM for the high-range; 0.3, 0.6, 0.9, 1.2 and 1.5 µM for the mid-range; and 0.04, 0.06,
0.08, 0.1 and 0.12 µM for the low-range.
Figure 1 shows the sensorgrams obtained from MCK experiments with the high-range
concentrations, while Figures 2 and 3 show the sensorgrams from SCK experiments obtained with
the mid- and low concentration ranges, respectively. For the high concentration range, MCK were
used as attempts with SCK resulted in very high RU levels with the initial injections, which saturated
the signal for subsequent additions. For all concentration ranges, data were fitted to a 1:1 Langmuir
model and a two-state reaction model, and the corresponding residual plots are shown along with
the fit of the model to the raw data in the sensorgrams. In addition to this, a steady-state fit with the
maximum binding response at equilibrium for each analyte concentration was conducted for all the
concentration ranges (see Figures S1–S3). Tables 1 and 2 report the estimates of the kinetic parameters,
resulting binding affinities, Rmax as well as the Chi2 and U-values for the 1:1 Langmuir model and the
two-state reaction model, respectively. Experiments were conducted three times with freshly prepared
POPC liposomes each time, and the data is reported as mean ± SEM.
Figure 1. Sensorgrams of the melittin–POPC (1-palmitoyl-2-oleoyl-glycero-3-phosphocholine)
interaction using multi-cycle kinetics for the high-range concentrations. Following immobilization of
POPC liposomes (1 mM lipid) to a binding response of 8400 RU, increasing concentrations of melittin
(0.5, 1, 2, 4 and 8 µM) were serially injected at a flow rate of 30 µL/min for 80 s with intermittent
regeneration cycles with 10 mM glycine–HCl (pH 2.5). Binding kinetics analysis of the sensorgrams with
a Langmuir 1:1 model (A) and a two-state reaction model (B) were conducted using BIAevaluation®
software. The estimated rate constants and affinity values, based on both these models, are listed in
Tables 1 and 2.
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Figure 2. Sensorgrams of the melittin–POPC interaction using single-cycle kinetics for the mid-range
concentrations. Following immobilization of POPC liposomes (1 mM lipid) to a binding response of
~4500 RU, increasing concentrations of melittin (0.3, 0.6, 0.9, 1.2 and 1.5 µM) were serially injected
in a single-cycle at a flow rate of 30 µL/min for 80 s with a single regeneration step with 10 mM
glycine–HCl (pH 2.5) at the end, i.e., after all five concentrations of melittin. Binding kinetic analysis of
the sensorgrams with a Langmuir 1:1 model (A) and a two-state reaction model (B) were conducted
using BIAevaluation® software. The estimated rate constants and affinity values, based on both these
models, are listed in Tables 1 and 2.
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Figure 3. Sensorgrams of the melittin–POPC interaction using single-cycle kinetics for the low-range
concentrations. Following immobilization of POPC liposomes (1 mM lipid) to a binding response
of ~3500 RU, increasing concentrations of melittin (0.04, 0.06, 0.08, 0.1 and 0.12 µM) were serially
injected in a single-cycle at a flow rate of 30 µL/min for 80 s with a single regeneration step with 10 mM
glycine–HCl (pH 2.5) at the end, i.e., after all five concentrations of melittin. Binding kinetics analysis
of the sensorgrams using a Langmuir 1:1 model (A) and a two-state reaction model (B) were conducted
using BIAevaluation® software. The estimated rate constants and affinity values, based on both these
models, are listed in Tables 1 and 2.
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Table 1. Kinetic and data-fitting parameters for melittin–POPC interactions based on a 1:1 Langmuir model. Data were measured at the three concentration ranges
and obtained from fitting sensorgrams to a 1:1 Langmuir model to obtain estimates of association (ka) and dissociation rates (kd) as well as binding constants (KD),
Rmax, Chi2 and U values. Uncertainties are given as mean ± SEM obtained from the curve fitting.
Analyte (Melittin) Concentration (µM) ka (M−1·s−1) kd (M−1·s−1) KD (M) Rmax (RU) Chi2 (RU) U-Value
0.5–8.0 (high-range) 2.2 ± 0.1 × 103 2.7 ± 0.1 × 10−3 1.2 ± 0.1 × 10−6 2841 ± 24 192 12
0.5–8.0 (high-range) +0.15 M NaCl 1.1 ± 0.3 × 103 8.2 ± 1.1 × 10−4 0.6 ± 0.3 × 10−6 2168 ± 28 198 12
0.3–1.5 (mid-range) 1.6 ± 0.2 × 104 7.4 ± 0.2 × 10−4 4.1 ± 0.1 × 10−8 216 ± 11 12 9
0.04–0.12 (low-range) 1.2 ± 0.3 × 105 5.7 ± 0.8 × 10−4 4.7 ± 0.6 × 10−9 197 ± 8 7 5
Table 2. Kinetic and data-fitting parameters for melittin–POPC interactions based on a two-state reaction model. Data were measured at the three concentration
ranges and obtained from fitting sensorgrams to a two-state reaction model to obtain estimates of association (ka1 and ka2) and dissociation rates (kd1 and kd2) as well
as binding constants (KD), Rmax and Chi2 values. Uncertainties are given as mean ± SEM obtained from the curve fitting.
Analyte (Melittin) Concentration (µM) ka1 (M−1·s−1) kd1 (s−1) ka2 (M−1·s−1) kd2 (s−1) KD (M) Rmax (RU) Chi2 (RU)
0.5–8.0 (high-range) 5.2 ± 0.1 ×103 4.7 ± 0.2 ×10−2 1.3 ± 0.01 ×10−2 3.1 ± 0.1 ×10−3 1.7 ± 0.2 ×10−6 3488 ± 48 134
0.5–8.0 (high-range) +0.15 M NaCl 2.2 ± 0.6 ×104 5.8 ± 1.2 ×10−2 3.8 ± 1.1 ×10−3 8.5 ± 0.7 ×10−4 0.5 ± 0.2 ×10−6 2725 ± 18 122
0.3–1.5 (mid-range) 4.6 ± 0.2 ×104 1.3 ± 0.1 ×10−2 3.4 ± 0.3 ×10−3 1.2 ± 0.3 ×10−6 1.5 ± 0.2 ×10−11 243 ± 13 7
0.04–0.12 (low-range) 2.1 ± 0.1 ×105 7.1 ± 0.1 ×10−3 5.2 ± 0.4 ×10−3 2.2 ± 0.8 ×10−6 1.5 ± 0.3 ×10−11 200 ± 9 3
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The 1:1 model assumes the formation of an analyte (A)-ligand (L) complex in a single step and






where ka is the association rate constant for formation of AL, and kd is the dissociation rate constant
for complex AL. While this is one of the most commonly used kinetic binding model in SPR analysis,
data from various studies indicates that the inherent assumptions of this model do not appropriately
explain the complex mechanism involved in the binding of AMPs to membranes [65]. In contrast,
the two-state reaction model assumes that the AL complex formed on the membrane surface undergoes
a change (either a conformational change, a change in agglomeration or orientation) to form AL* and










where ka1 is the association rate constant for formation of AL, kd1 is the dissociation rate constant for
complex AL, ka2 is the association rate constant for conversion of AL to AL*, and kd2 is the dissociation
rate constant for conversion of AL* to AL. The model assumes that the formation of AL* (and back) can
only go via AL (i.e., A and L cannot form AL* and AL* cannot breakup without going through the state
AL). It also assumes that the formation of AL follows first-order kinetics and that the rate of change is
equal in both directions [74]. Note that it is not possible by SPR alone to determine the exact nature of
the AL complex or determine the type of change that the complex undergoes between AL and AL*.
Comparison of the sensorgrams across the three concentration ranges used shows that one of the
striking differences among the experiments at different concentration ranges were the Rmax values.
In the low- and mid concentration ranges, Rmax levels are ~200 RU (Tables 1 and 2). In contrast, for the
high concentration range, Rmax reached much higher levels (>2800 RU and >3400 RU for the 1:1 and
two-state model, respectively). Interestingly, the difference in Rmax values between mid- and low
concentration ranges is substantially smaller to that observed in the high concentration range. This is
observed in both the 1:1 and the two-state reaction models (Tables 1 and 2). This is consistent with the
widely accepted view that the binding of melittin to lipids is not based on the absolute concentration
of the peptide, but rather it is determined by the peptide/lipid (P/L) ratio [26].
Comparison of the residual plots for the three concentration ranges, for both the 1:1 and two-state
reaction models, shows that the fits were much better in the mid- and low concentration ranges than in
the high concentration range. This is reflected quantitatively in the corresponding Chi2 and U-values
(Tables 1 and 2). Chi2 measures the average deviation of the experimental data from the model and
is an overall measure of the “goodness of fit”, with values below 10% of Rmax being considered as
a good fit. U-values are a measure of the “uniqueness” of the predicted KD value with a lower U-value
indicating greater confidence in the predicted value. With the 1:1 model the Chi2 values range from 3%
for the low concentration range to 7% for the high concentration range. With the two-state model the
Chi2 values range from 2 to 4%. Similarly, the U-values are lower for the mid- and low concentration
ranges than the high concentration range, indicating greater confidence in the estimated KD values for
mid- and low concentration ranges compared to high concentration range. The Chi2 and U-values
are lower for the two-state model compared to the 1:1 model, indicating that the fit is much better
for the former. This is consistent with observations from previous SPR studies of melittin by Aguilar
and co-workers [62,65] whose comparison of the 1:1 model, a parallel model and the two-state model
suggested that the fit for the latter is comparatively better.
Comparison of kinetic rate constants and the binding affinity from the different concentration
ranges of melittin (analyte) used in this study indicate that these parameters are concentration
Int. J. Mol. Sci. 2020, 21, 746 9 of 20
dependent. This is true for both the 1:1 and the two-state model. While the absolute values of the
kinetic rates and binding affinities are different between the models, the concentration-dependent trends
are the same. Also, it is generally recommended to use a concentration range that the expected KD value
lies within the range of concentrations used to derive that KD value. The KD value, estimated as per
the steady-state fit, for all three concentration ranges are within the analyte concentration range used;
this is shown in the Supplementary Materials (Figures S1–S3). A steady state affinity measurement
is based on the plot of responses at equilibrium states against the concentrations of analyte used in
the assay. However, it is notable that the KD values estimated using kinetic measurements (i.e., the ka
(on-rate) and kd (off-rate) values), especially for the mid and low concentration ranges, were outside
the analyte concentration range. This could be due to the fact of several reasons; in principle, the rate
constants ka and kd and the KD derived from these rate constants are independent of both analyte and
ligand concentrations. Secondly, as can be noted in Tables 1 and 2, the concentration-dependent effect
on the change in affinity (KD) was higher due to the increasing on-rate (ka) than due to the observed
decrease in the off-rate (kd). Other factors that may affect the KD, such as the pH, temperature etc.,
were kept constant across the experiments.
In both models, the association is slower in the high concentration range than in the low
concentration range. For example, in the two-state model, the rate for the initial surface binding (ka1)
was 2.1 × 105 M−1·s−1 for the low concentration range, and it dropped to 4.1 × 104 M−1·s−1 for the
mid concentration range. The ka1 further decreased to 5.2 × 103 M−1·s−1 for the high concentration
range (Table 2). In other words, a 100-fold increase in concentration resulted in an approximately
100-fold decrease in the association rate. The association rates (ka1 and ka2) derived from the two-state
reaction model also suggested that the initial binding to form the AL complex was much more rapid
than the subsequent transition to AL*, and that ka1 was affected more by the concentration than ka2.
Nevertheless, in both models all association rates decreased with increasing peptides concentrations.
This is inconsistent with previous findings reported by Aguilar and co-workers [62], where the
association for a 0.125–1 µM concentration range was found to be slow, while rapid association was
observed at higher concentrations (4–12 µM). However, this observation was based on a qualitative
assessment of sensorgrams rather than a quantitative analysis, as the authors concluded that the latter
was not possible due to the poor fit of their experimental data which may likely be due to the very high
RU levels. In addition, the conclusion about the absence of binding at low concentrations was based on
a comparison of the RU levels at low peptide concentrations (which were well below 200 RU) to the RU
levels at high peptide concentrations (which were in the range of 3000–7000 RU). A semi-quantitative
comparison of data with such different RU levels is likely less reliable than the analysis of binding
kinetics rates derived from the sensorgrams.
Comparison of the dissociation rates from the different concentration ranges suggests that kd
might depend more on the number of analyte–ligand complexes formed (as given by Rmax values)
rather than the analyte concentration. In the 1:1 model this can be seen by comparing the kd of the
mid and low concentration ranges to the high concentration range. The kd values from the mid and
low concentration ranges were close to each other and both concentration ranges showed low RU
levels. For the high concentration range, where the RU level was much higher, kd deviated by an order
of magnitude to that in the other two concentration ranges. A similar effect was seen for kd1 in the
two-state model.
As a result of these concentration-dependent changes in the association and dissociation rates,
the binding constant KD differed by orders of magnitudes for the low, mid and high concentration
ranges. For both binding kinetics models, KD was in the µM (10−6) range for the high concentration
range but shows nM (10−9) and sub-nM affinity for the low concentration range in the 1:1 and two-state
reaction models, respectively.
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2.2. Effects of NaCl on the Melittin–POPC Interaction
Ionic strength is known to affect the biological activity of AMPs [75] including the oligomerisation
of melittin in solution [29,70,71]. To assess the effect of NaCl on the binding of melittin to POPC,
experiments with melittin in the high concentration range (0.5 to 8 µM) were conducted in the presence
of 0.15 M NaCl in the running/analyte buffer. Figures 4 and 5 show the sensorgrams for MCK and SCK
for the melittin–POPC interaction in the presence of 0.15 M NaCl, fitted to 1:1 and two-state reaction
models, respectively. Comparison of this figure with the sensorgrams obtained in the absence of NaCl
(Figure 1) suggests that addition of NaCl results in a decrease in signal response during the association
phase for almost all of the concentrations. Consequently, the sensorgrams did not have the desired
curvature optimal for performing fitting analysis. However, the curve-fitting step was conducted for
experiments involving the use of NaCl and the estimates are reported, but no major conclusions were
made using the estimates. Comparison of the Rmax levels in Tables 1 and 2 shows that the drop from
2841 RU to 2168 for the 1:1 model and from 3488 to 2725 RU in the two-state model, corresponds to
~20%–25% reduction in Rmax. This decrease in signal response resulted in only a small decrease in the
association rate (ka) in the 1:1 model (Table 1). In the two-state model, it was ka2 that was reduced,
while ka1 slightly increased in the presence of NaCl. In both models, the dissociation rate (kd for the 1:1
model and kd1 for the two-state model) was also reduced, more so than the reduction in ka. As a result,
there was an overall small increase in affinity upon addition of NaCl.
Figure 4. Effect of sodium chloride on the association phase of the melittin–POPC interaction.
Following immobilization of POPC liposomes (1 mM lipid), increasing concentrations of melittin (2,
4, 6, 8 and 10 µM) were serially injected with intermittent regeneration cycles with 10 mM glycine–HCl (pH:
2.5) (A—multi-cycle) and single regeneration using the same buffer at the end of all cycles (B—single-cycle).
The estimated rate constants and affinity values, based on both these models, are listed in Tables 1 and 2.
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Figure 5. Effect of sodium chloride on melittin–POPC interaction—single-cycle kinetics.
Following immobilization of POPC liposomes (1 mM lipid), increasing concentrations of melittin
(0.5, 1, 2, 4 and 8 µM), made up in running buffer containing 0.15 M NaCl, were serially injected,
following a single-cycle kinetic approach. The sensorgrams were fitted to a 1:1 Langmuir model (A)
and two-state reaction model (B) using BIAevaluation® software. The estimated rate constants and
affinity values, based on both these models, are listed in Tables 1 and 2.
3. Discussion
This study aimed to quantify the effect of peptide concentration on the kinetics and affinity of
melittin binding to POPC bilayers. The kinetics of the melittin–POPC interaction was studied at three
different concentration ranges spanning two orders of magnitude. To understand the mechanism
of melittin (and other AMPs), it is not so much the actual concentration of peptide present that is
important but the relative amounts of peptide and lipid, i.e., the P/L ratio. The analyte concentrations
used in this study correspond to the following P/L ratios: high range concentration (0.5–8 µM) is
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a P/L of ~1/2000 to 1/125; mid range concentration (0.3–1.5 µM) is a P/L of ~1/3330 to 1/660; low range
concentration (0.04–0.12 µM) is a P/L of ~1/20,000 to 1/8300.
As noted in the introduction, there have been previous studies reporting the binding affinity of
melittin for phospholipid bilayers. When comparing binding affinities for peptide–membrane systems,
it is important to consider the technique or assay used as this often dictates the theoretical model used
to analyse the data. In SPR, KD is calculated using binding kinetics rates and/or Langmuir adsorption
isotherms or related binding models. In contrast, data from ITC, NMR or filtration experiments of
peptide–membrane systems can be analysed using a surface partition equilibrium model. In this case,
a partition coefficient Kp, rather than KD, is calculated. Kp is given by the ratio of peptides bound to the
membrane and peptides remaining in solution, while electrostatic effects are corrected for by using the
Gouy–Chapman theory [76]. A direct comparison of the raw data between these types of experiments
or analysis using both models is often not possible. In both cases, the free energy associated with the
binding affinity is given by ∆G = −RT ln(K), where R is the gas constant, T is the temperature in Kelvin
and K is either Kp or 1/KD. Nevertheless, the underlying assumptions in these models are different and
affinities for the same system under the same conditions can vary [77]. In the following discussion,
the ∆G = −RT ln(K) relation is used for comparison of data from ITC and NMR experiments from
previous studies and the SPR data from this study.
In one of the earliest studies of melittin binding to membranes, Vogel [35] used circular dichroism
(CD) and fluorescence spectroscopy to estimate the binding affinity of melittin to DMPC vesicles.
The lipid and peptide concentration used in that study correspond to P/L ratios between 1/10 to 1/250
which is comparable to the upper end of the high concentration range used in this study. The KD
from the CD titration experiments was calculated using a binding isotherm and estimated to be 2 µM
which is in very good agreement with the binding affinities of 1.2 µM and 1.7 µM of our experiments.
Allende et al. [55,59] used an ultrafiltration assay to study the interaction of melittin with membranes
of a wide range of different lipid compositions including egg phosphatidylcholine (EPC) and DOPC
vesicles. The P/L ratios ranged from 1/300 to 1/600, corresponding to our high concentration ranges.
The Kp values for EPC and DOPC were ~3.6 µM, slightly higher but still in good agreement with our
results. In two NMR studies, Beschiaschvili et al. [60,78] estimated the binding affinity of melittin to
POPC vesicles using P/L ratios from ~1/600 to 1/1400. This corresponds to the lower part of the high
range and upper part of the mid range from our experiments. The Kp was estimated between 1.5 to
2 µM. This agrees with our KD values for the high concentration range but not for the values in the mid
concentration range, which are estimated to be much lower (sub-µM and nM range). However, a direct
comparison of the KD values from our SPR experiments to the Kp values from the NMR is complicated
by the fact that, based on our findings, the concentration range used in the NMR experiments is where
the effect of concentration is the largest. Another difference is that in the aforementioned studies the
size of the vesicles used ranges from 1–10 µM which is 20–200 times larger than the vesicles used in this
study. This difference in size implies differences in the curvature of the membrane surface, which can
affect the peptide-lipid interaction.
The only other SPR study that used quantitative analysis to report KD values of melittin binding to
PC-only membranes is that by Lee et al. [64], where the binding of melittin to DMPC was studied. The KD
value was estimated to be 33 µM for P/L ratios between 1/3 and 1/100 which is higher than the highest
concentration used in our study. This could be the result of the very high P/L ratio or the fact that supported
lipid monolayers formed on an HPA chip instead of the intact bilayer vesicles used in this study. In our
experiments, we assumed that the vesicles (ligand) stay intact after immobilization [79]. The tighter lipid
packing of a supported bilayer compared to SUVs might cause slightly reduced binding [80].
In another SPR study, Papo et al. [68] quantified the kinetics and affinity of binding of melittin to
POPC/chol (10:1 w/w) vesicles using P/L ratios between ~1/1600 and ~1/3300. This corresponds roughly
to the low range concentrations used in our study. Data were analysed using a two-state model, and the
KD estimated based on this model was 1.6 µM. This is significantly lower than the KD determined
in the sub-nM range for our low concentration. While the study by Allende et al. [55] showed that
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cholesterol can lower the binding affinity by 1–2 orders of magnitude, there is still a large difference
between the KD reported by Papo et al. and our estimates in this study. We note, however, that the
value of ka1 reported by Papo et al. was very low and could possibly be below the acceptable detection
limit of the Biacore X instrument used in their experiments. We speculate this based on the acceptable
limits for the kinetic binding constants for the Biacore T200 instrument used in this study which is
a more sensitive instrument with a wider detection limit compared to the Biacore X instrument.
Overall, the results of our SPR experiments for the high concentration range are in good agreement
with the binding affinities from earlier studies. Combined with the fact that our estimates of the binding
affinities in the mid- and low-range concentrations are more reliable, it increases our confidence in the
predicted effect of concentration on the kinetics and binding affinity in the mid- and low concentration
ranges. We can now interpret our finding that the apparent binding affinity of melittin for POPC
decreases with increasing P/L ratio in the context of what is known about the mechanism of action
of melittin.
As mentioned in the introduction, a number of studies have shown that melittin can orient itself
into different orientations with respect to the bilayer surface: in a parallel orientation, where the peptide
lies flat on the membrane surface, and a perpendicular orientation where the peptide inserts into the
hydrophobic core region of the bilayer. The parallel orientation is often referred to as the ‘inactive’ state,
as there is evidence suggesting that this orientation is non-pore forming and non-lytic. In contrast,
the perpendicular orientation is the ‘active’ state that results in the formation of the pores [26,81,82].
In the original two-state model [41] the peptide binds to the surface and then transitions from the
parallel to the perpendicular orientation. In an alternative model, parallel surface binding and direct
insertion are competing processes [26]. Independent of the mechanism, there is evidence that suggests
that the most important factor controlling the amount of peptides found in the parallel or perpendicular
orientation is the P/L ratio [26,81]. Yang et al. [81] used oriented CD spectroscopy and neutron
scattering to demonstrate that at melittin concentrations corresponding to a P/L ratio of ~1/40, 85% of
peptides were orientated parallel to the membrane surface. At peptide concentrations corresponding
to a P/L ratio of ~1/15, 68% of peptides were orientated perpendicular to the membrane. Another study
demonstrated that at higher P/L ratio, melittin inserts perpendicularly into the hydrophobic core of the
bilayer, to translocate and redistribute on either side of the bilayer [54]. This study suggests that the
redistribution of melittin on either side of the bilayer at a higher P/L ratio (~1/100) occurs due to the
formation of transient but not stable pores, and that the latter occur only above a critical P/L ratio (~1/45).
Interestingly, the formation of such transient pores in phospholipid bilayers by the action of melittin
has also been observed at concentrations as low as a P/L of 1/5000. For SUVs, this P/L ratio corresponds
to the low- and mid-range concentrations used in this study. Similarly, the existence of transient pores
induced by melittin and the subsequent ‘re-sealing’ has been shown in bacterial membranes [72].
Based on these findings, a variant of the binding kinetics model of the classical carpet model has been
proposed, in which permeabilisation of membranes by cationic amphipathic peptides is transient and
stochastic on the scale of a single vesicle or bacteria [40,72,83,84]. Peptides accumulate on the bilayer
surface, causing an asymmetry in peptide concentration across the bilayer, i.e., an asymmetry in mass,
charge and surface pressure on the bilayer. Subsequently, this asymmetry is abolished by a set of
stochastic membrane re-organization events, resulting in the influx of peptide molecules across the
bilayer until equilibrium in concentration is attained. Finally, simulations show that while the energy
barrier for the reorientation of single peptide is large, the barrier is reduced by a higher P/L as well as
by the presence of transient water-filled pores in the membrane [45,85].
Based on the above findings, we can assume the following conditions at the low- and mid
concentration ranges used in our experiments: the vast majority of peptides are found in parallel
orientation and no stable pores are present, but transient pores might stochastically form and ‘re-seal’.
This means that at a low P/L ratio, any additional increase in peptide concentration results in
an accumulation of peptides on the membrane surface creating an accumulation of positive charge,
leading to an increase in the repulsion for subsequent peptide binding. This could explain the
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continuous decrease in the association rates (ka1 and ka) with increasing concentration of melittin
observed in this study. The largest effect of concentration on KD occurs when going from the
mid- to the high concentration range, which goes from supra-nM to µM range. The upper range
of the high concentration range in this study reaches a P/L ratio where the presence of peptides
found in the perpendicular orientation is increasingly likely. This is consistent with the fact that
concentration ranges used in this study were relevant to the concentration of melittin required to
induce leakage [17,18,24,25,55,57] and the minimum inhibitory concentration of melittin on bacteria.
Our experiments also showed that binding kinetics parameters were also affected by the choice
of binding model. At all concentrations, a two-state reaction model gives the best fit to the data,
suggesting that it is better at describing the process of binding than a 1:1 model. At first this appears
to confirm the classical two-state model of melittin binding and pore formation [41] which involves
the transition from a parallel to a perpendicular orientation, excluding the model where parallel
adsorption and perpendicular insertion are described as competing processes [26]. However, our
findings only confirm that a two-state model provides a better description of binding than the 1:1
model, but cannot exclude the parallel–perpendicular competition model [26]. This would only be
possible by a direct comparison of data fitted to both of these models. We note that the conventional
binding models used in this study do not account for any electrostatic effects. The CD spectroscopy
experiments by Beschiaschvili et al. [60] demonstrated that melittin binding to lipids (SUVs) decreased
as the membrane surface charge was neutralized by previously bound melittin. This effect was
observed to be higher in zwitterionic lipids (POPC) than hybrid SUVs (80/20 POPC/POPG). If taken into
account, the influence of electrostatic effects could potentially correspond to the transition from positive
to negative cooperativity in melittin–membrane interactions which, to the best of our knowledge,
cannot be qualitatively assessed by SPR.
In addition to the effect of peptide concentration on the kinetics and affinity of binding, we also
investigated the effect of physiological ionic strength (0.15 M NaCl) on the interaction of melittin with
POPC bilayers. At the pH, ionic strengths and peptide concentrations used in this study, melittin is be
expected to remain in its monomeric form [28,29,69–71]. In the presence of NaCl, an apparent decrease
in the signal response during the association phase was observed in both single and multi-cycle kinetics
experiments, leading to a somewhat reduced association rate (ka). This could be caused by a screening
effect of the NaCl between the cationic peptide and the zwitterionic membrane. Another reason
could be that the binding of Na+ ions to the membrane surface changes the electrostatics of the
water-lipid interfacial region. Several studies have shown that Na+ ions can bind to phospholipid
bilayers, where they interact with the phosphate and carbonyl oxygen of the lipid headgroups [86,87].
The binding of Na+ shields the negative charge of the phosphate group and, thus, indirectly increases
the electrostatic charge of the membrane (as there are now more unbound positively charged choline
groups than negatively charged phosphate groups). As the initial association is likely driven by
electrostatics, this could account for the reduced ka in the presence of NaCl. Further characterisation of
the melittin–POPC interaction with a range of NaCl concentrations will be needed to better understand
this effect. Also, future studies should focus on the use of complex cell membrane models (e.g., hybrid
lipid systems or virus-like particles derived from mammalian cell models) that could enable interaction
studies in a more physiologically relevant context.
4. Materials and Methods
4.1. Materials
The POPC (1-palmitoyl-2-oleoyl-glycero-3-phosphocholine) was purchased from Avanti Polar
Lipids (Birmingham, USA) through Sigma–Aldrich (Castle Hill, Australia). Mechanical extrusion
for the preparation of lipid vesicles was carried out using an extruder from Avanti Polar Lipids
(Birmingham, USA). Melittin was purchased from AnaSpec (Fremont, USA). Reagents for buffer
solutions, glycine-HCl and CHAPS (3-((3-cholamidopropyl) dimethylammonio)-1-propanesulfonate)
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solutions were purchased from Sigma–Aldrich (Castle Hill, Australia). Running buffer for SPR
experiments consisted of 0.05 M HEPES (Sigma–Aldrich, Australia) at a pH of 7.4 and also included
150 mM NaCl for experiments investigating the effect of ionic strength. The SPR experiments were
conducted in a BiacoreT200 instrument using a L1 sensor chip S series (GE Healthcare Life Sciences,
Paramatta, Australia).
4.2. Liposome Preparation
The POPC vesicles at a 1.0 mM lipid concentration were used for all experiments in this study and
were prepared as follows. First, the required amount of POPC was weighed in a glass vial, dissolved in
chloroform and dried under a narrow jet of nitrogen gas. Complete dehydration of the lipid film was
ensured by placing the vial in a vacuum desiccator attached to a pump for at least 12 h. The resulting
lipid film was rehydrated with running buffer to a final lipid concentration of 1.0 mM. The solution
was vortexed for 1 h and allowed to stand for at least 2 h or to a maximum overnight period to
enable osmotic swelling. A uniform population of small unilamellar vesicles (SUVs) was obtained
by mechanical extrusion through a polycarbonate filter with pore size of ~50 nm for at least 21 times.
This approach was previously shown to be effective in attaining a higher degree of homogeneity and
reproducibility in nanosizing liposomes compared to other commonly used approaches for generating
SUVs [88].
4.3. Surface Plasmon Resonance Experiments
4.3.1. Immobilization of POPC Vesicles on a L1 Chip
The L1 sensor chip was equilibrated at room temperature and then docked into a BiacoreT200
instrument. After priming the system with running buffer, a manual run was set-up for three
consecutive injections with running buffer containing 20 mM CHAPS at a flow rate of 30 µL/min.
This washing step was conducted in every subsequent use of the chip before and after the binding
experiments. The POPC SUVs of ~50 nm diameter at a 1.0 mM lipid concentration were then steadily
immobilized on to the L1 chip surface through a manual run at a flow rate of 5 µL/min. The target
immobilization levels varied from ~4000 to 8000 RU, based on the concentration of melittin used in the
binding assay. Following liposome immobilization, a short pulse with running buffer was injected at
a flow rate of 2 µL/min for 5 min to ensure the stability of the baseline in the flow cell containing the
immobilized vesicles.
4.3.2. Binding experiments
Melittin solutions at the desired range of concentrations were prepared in running buffer by
dilution from a stock solution (2.2 mM). Melittin solutions were also prepared in a running buffer
containing 0.15 M NaCl, the POPC SUVs were prepared in a running buffer without NaCl, while all
other experimental conditions were the maintained as same as in the experiments conducted in the
absence of NaCl. The kinetics of the melittin–POPC interactions were estimated using either single or
multi-cycle kinetics. Melittin solutions were serially injected at increasing concentrations at 30 µL/min,
with (multi-cycle) or without (single-cycle) intermittent regeneration cycles among various analyte
injections, using 10 mM glycine–HCl, pH 2.5.
In a single-cycle kinetics experiment increasing concentrations of analyte are serially injected
with a single dissociation phase after the injection of the highest concentration. It should be noted
that, although this approach includes only a single dissociation phase at the end, there is a short pulse
of running buffer after each analyte injection period during when some dissociation can be noted.
Depending on the rate of dissociation, it is possible that some analyte remains bound to the immobilized
ligands before the next injection. However, the fitting models used for the analysis of single-cycle
kinetic experiments account for the varying concentrations of analyte injections in time and different
amounts of preformed ligand–analyte complexes on the surface [89]. The fact that in a single-cycle
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kinetic experiment there is no intermittent regeneration cycles, it can be advantageous as it prevents
the detrimental effects of a strong acidic regeneration buffer on the ligand. Single-cycle and multi-cycle
approaches differ in their experimental procedure but have been shown to yield comparable results.
Nevertheless, the single-cycle approach can be challenging for high analyte concentrations, because the
number of ligand–analyte complexes being formed after initial analyte injections can substantially
impair analyte binding in subsequent injections. Therefore, a multi-cycle approach, which includes
separate association, dissociation and regeneration phase for each analyte injection, is used only for
the high-range analyte concentration in this study.
4.4. Curve Fitting
All sensorgrams obtained from single- and multi-cycle kinetic analyses were fitted using either
the 1:1 Langmuir model or the two-state reaction model available in the BIAevaluation® software
version 1.0 (GE Healthcare Life Sciences, Paramatta, Australia) to estimate ka, kd and KD. The curve
fitting procedure is an iterative numerical process that determines the best fit of experimental data
to the set of equations specific for a binding kinetics model (e.g., the 1:1 Langmuir or the two-state
reaction model) thus defining the interaction and yielding the kinetic rate constants (ka and kd) from
which the binding constants (KD) can be determined. The “goodness of fit” for the fitted curve is
given by Chi2. In addition, residual plots show the magnitude of the deviation (in units of RU) of the
experimental data from the fitted data as a function of time. The experimental data are shown as solid
lines and the fitted data as dotted lines in all of the sensorgrams. The quality of fit and reliability of
the estimated binding parameters were assessed by the Chi2 and U-values (only for the Langmuir 1:1
model), respectively.
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